---
schema_version: "secwatch.filing_event.v1"
accession: "0001378325-26-000026"
form_type: "8-K"
ticker: "CV"
cik: "0001378325"
company_name: "CapsoVision, Inc"
filed_at: "2026-07-02T20:10:05+00:00"
generated_at: "2026-07-02T20:11:13.725840+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# CapsoVision appoints Dr. David Shields to board; Dr. Imperial resigns but remains consultant

## Summary
- Dr. David Shields, a gastroenterologist with 40+ years experience and capsule endoscopy pioneer, appointed Class I director and Compensation Committee member effective July 1, 2026.
- Dr. Joanne Imperial resigned as director effective July 1, 2026; no disagreement with management or board.
- Dr. Imperial will continue as independent consultant at $600/hour, up to 5 hours/week, and received option for 10,000 shares vesting over 4 years.
- Dr. Shields will provide clinical consulting at $600/hour, up to 3 hours/week, under a separate consulting agreement.
- Dr. Imperial to advise on pancreatic cancer program and planned 2027 esophageal varices study using next-gen capsule platform.

## SEC filing metadata
- accession: 0001378325-26-000026
- form_type: 8-K
- ticker: CV
- cik: 0001378325
- company_name: CapsoVision, Inc
- filed_at: 2026-07-02T20:10:05+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1378325/000137832526000026/0001378325-26-000026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1378325/000137832526000026/cv-20260701.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001378325-26-000026
- JSON: https://secwatch.observer/filing/0001378325-26-000026.json
- Plain text: https://secwatch.observer/filing/0001378325-26-000026.txt

## Key facts
- Executive change
  Dr. David S. Shields was appointed as Class I director at CapsoVision, Inc.
  - Action: appointed
  - Role: Class I director
  source text: On July 1, 2026, the Board of Directors (the “Board”) of CapsoVision Inc. (the “Company”) appointed Dr. David Stanley Shields to serve as a Class I director of the Board and as a member of the Compensation Committee of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1378325/000137832526000026/0001378325-26-000026-index.htm
- Executive change
  Dr. Joanne Imperial departed as Class I director at CapsoVision, Inc.
  - Action: stepped down
  - Role: Class I director
  source text: On July 1, 2026, Dr. Joanne Imperial stepped down from the Board as a Class I director and as a member of the Compensation Committee of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1378325/000137832526000026/0001378325-26-000026-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.